Nothing Special   »   [go: up one dir, main page]

GB9201391D0 - Method of treatment - Google Patents

Method of treatment

Info

Publication number
GB9201391D0
GB9201391D0 GB929201391A GB9201391A GB9201391D0 GB 9201391 D0 GB9201391 D0 GB 9201391D0 GB 929201391 A GB929201391 A GB 929201391A GB 9201391 A GB9201391 A GB 9201391A GB 9201391 D0 GB9201391 D0 GB 9201391D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929201391A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB929201391A priority Critical patent/GB9201391D0/en
Publication of GB9201391D0 publication Critical patent/GB9201391D0/en
Priority to JP5513015A priority patent/JPH07503243A/en
Priority to EP93902424A priority patent/EP0621778A1/en
Priority to AU33612/93A priority patent/AU3361293A/en
Priority to PCT/GB1993/000125 priority patent/WO1993014752A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB929201391A 1992-01-22 1992-01-22 Method of treatment Pending GB9201391D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB929201391A GB9201391D0 (en) 1992-01-22 1992-01-22 Method of treatment
JP5513015A JPH07503243A (en) 1992-01-22 1993-01-20 Treatment of M. fermentans infections
EP93902424A EP0621778A1 (en) 1992-01-22 1993-01-20 $i(M. FERMENTANS) INFECTION TREATMENT
AU33612/93A AU3361293A (en) 1992-01-22 1993-01-20 (M. fermentans) infection treatment
PCT/GB1993/000125 WO1993014752A1 (en) 1992-01-22 1993-01-20 M. fermentans infection treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929201391A GB9201391D0 (en) 1992-01-22 1992-01-22 Method of treatment

Publications (1)

Publication Number Publication Date
GB9201391D0 true GB9201391D0 (en) 1992-03-11

Family

ID=10709071

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929201391A Pending GB9201391D0 (en) 1992-01-22 1992-01-22 Method of treatment

Country Status (5)

Country Link
EP (1) EP0621778A1 (en)
JP (1) JPH07503243A (en)
AU (1) AU3361293A (en)
GB (1) GB9201391D0 (en)
WO (1) WO1993014752A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7649098B2 (en) 2006-02-24 2010-01-19 Lexicon Pharmaceuticals, Inc. Imidazole-based compounds, compositions comprising them and methods of their use
TW200920355A (en) 2007-09-06 2009-05-16 Lexicon Pharmaceuticals Inc Compositions and methods for treating immunological and inflammatory diseases and disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563067B2 (en) * 1982-02-27 1987-06-25 Beecham Group Plc Heterocyclic normonyl derivatives
MX9100367A (en) * 1990-08-01 1992-04-01 Beecham Group Plc DERIVATIVES OF HETEROARILCETONE AND PROCEDURE FOR ITS PREPARATION

Also Published As

Publication number Publication date
EP0621778A1 (en) 1994-11-02
WO1993014752A1 (en) 1993-08-05
AU3361293A (en) 1993-09-01
JPH07503243A (en) 1995-04-06

Similar Documents

Publication Publication Date Title
GB9027968D0 (en) Method of treatment
GB9218027D0 (en) Novel method of treatment
GB9202196D0 (en) Method of treatment
GB9201391D0 (en) Method of treatment
GB9218597D0 (en) Novel method of treatment
GB9415902D0 (en) Method of treatment
GB9407335D0 (en) Method of treatment
GB9202698D0 (en) Method of treatment
GB9226252D0 (en) Method of treatment
GB9223252D0 (en) Method of treatment
GB9218188D0 (en) Method of treatment
GB9207275D0 (en) Method of treatment
GB9202020D0 (en) Method of treatment
GB9226371D0 (en) Novel method of treatment
GB9321796D0 (en) Method of treatment
GB9321971D0 (en) Method of treatment
GB9307004D0 (en) Method of treatment
GB9414652D0 (en) Method of treatment
GB9101001D0 (en) Method of treatment
GB9101000D0 (en) Method of treatment
GB9101176D0 (en) Method of treatment
GB9104267D0 (en) Method of treatment
GB9105617D0 (en) Method of treatment
GB9101175D0 (en) Method of treatment
EP0705104A4 (en) Method of cancer treatment